CTLA4 and neoplasm: PD1 and CTLA4 are T cell-expressed immunomodulatory receptors, whereas PD-L1 (to PD1) and CD80 (to CTLA4) are binding partners present on tumor cells and macrophages, and dendritic cells, respectively.